You are here

Europe

Novartis strikes out with dry eye med Xiidra in Europe

Seeking Alpha

Fri, 06/26/20 - 09:52 am

dry eye disease

COVID-19 drug remdesivir recommended for EU approval

Pharmaforum

Fri, 06/26/20 - 09:43 am

BioGeneration Ventures €105M fund for early European biotechs

Fierce Biotech

Wed, 06/24/20 - 11:13 am

BioGeneration Ventures

venture capital

Biopharma industry urges MRA to mitigate risk of no-deal Brexit

RAPS.org

Fri, 06/19/20 - 10:47 am

Some Covid-19 trial sponsors never posted other study results in an EU database. Will they hide data again?

Stat

Wed, 06/17/20 - 09:55 pm

clinical trials

clinical trial transparency

AstraZeneca to supply Europe with up to 400 million doses of Oxford University’s vaccine at no profit

Pharmaceutical Business Review

Mon, 06/15/20 - 10:28 am

University of Oxford

Surmodics' Regulatory Win Marks a Positive Shift in Paclitaxel Controversy

Medical Devices and Diagnostics Industry

Sat, 06/13/20 - 11:28 pm

EU states back spending up to $2.7 billion upfront on COVID-19 vaccines

Reuters

Fri, 06/12/20 - 08:06 pm

Gilead files remdesivir for EU approval, with a verdict possible “in weeks”

Pharmaforum

Tue, 06/9/20 - 10:36 am

Gilead Sciences

Europe mulls BARDA-style development contracts for COVID-19 vaccines: Bloomberg

Fierce Pharma

Thu, 06/4/20 - 11:23 am

EMA weighs COVID-19 data transparency, not ready to resume full clinical data publication

RAPS.org

Tue, 06/2/20 - 11:00 am

clinical trial transparency

EMA extends virtual-only meeting policy through August

Endpoints

Thu, 05/21/20 - 10:47 am

New Zolgensma 'inflection point' is here as Novartis snags EU nod for SMA gene therapy

Fierce Pharma

Wed, 05/20/20 - 10:50 am

spinal muscular atrophy

World leaders pledge €7.4bn to research Covid-19 vaccine

The Guardian, UK

Wed, 05/6/20 - 12:06 am

EMA gives thumbs up to key drugs from Novartis, Alexion, Vertex and more

Endpoints

Fri, 05/1/20 - 12:43 pm

Vertex Pharmaceuticals

After NIH trial, EMA begins rolling review for remdesivir, setting up potential authorizations in US and Europe

Endpoints

Thu, 04/30/20 - 10:43 pm

Gilead Sciences

FDA, EU authorities update guidance on clinical trials during COVID-19

RAPS.org

Tue, 04/28/20 - 11:52 pm

clinical trials

Takeda to sell European OTC business to cut debts

Pharmaforum

Fri, 04/24/20 - 10:53 am

Sanofi CEO Hudson continues crusade for European pandemic muscle

Fierce Pharma

Thu, 04/23/20 - 11:04 am

EMA details new drug supply monitoring system for COVID-19

RAPS.org

Wed, 04/22/20 - 12:02 am

Pages